OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
45
Results
Show all
Save search
Copy query
Show results for
Unknown
(45)
Publication Date
Release Date
2021
(14)
2023
(12)
2022
(9)
2024
(4)
2025
(2)
2020
(2)
2017
(1)
2016
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Extensive genetic diversity of Plasmodium vivax dbp-II in Rio de Janeiro Atlantic Forest and Brazilian Amazon Basin: evidence of positive selection.
Not available
S-EPMC7031913
|
biostudies-literature
Cite
Comprehensive probiogenomics analysis of the commensal Escherichia coli CEC15 as a potential probiotic strain.
Not available
S-EPMC10680302
|
biostudies-literature
Cite
Genomic history of coastal societies from eastern South America.
Not available
S-EPMC10406606
|
biostudies-literature
Cite
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
Not available
S-EPMC8362594
|
biostudies-literature
Cite
Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children.
Not available
S-EPMC7614690
|
biostudies-literature
Cite
Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled Trial.
Not available
S-EPMC10629360
|
biostudies-literature
Cite
ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing.
Not available
S-EPMC7809782
|
biostudies-literature
Cite
Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial.
Not available
S-EPMC9646993
|
biostudies-literature
Cite
Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.
Not available
S-EPMC7616346
|
biostudies-literature
Cite
Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial.
Not available
S-EPMC9630157
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets